Relapsed and Refractory Aggressive B- and T-cell Lymphomas
1 clinical trials · Condition
◉ Watch Relapsed and Refractory Aggressive B- and T-cell Lymphomas
| Record | Firm | Date |
|---|---|---|
| Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas (NCT02875002) | Yale University | 2016-10-01 |
Track Relapsed and Refractory Aggressive B- and T-cell Lymphomas automatically
Every clearance here is in the API, with alerts when new ones post.